Hemophilia A historical perspective: Difference between revisions
Fahd Yunus (talk | contribs) |
Fahd Yunus (talk | contribs) |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Hemophilia is sometimes referred to as “The Royal Disease”, as it affected many members of the English, German, Russian and Spanish monarchies in the 19th and 20th centuries. | |||
==Historical Perspective== | ==Historical Perspective== |
Revision as of 22:01, 29 July 2016
Hemophilia A Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hemophilia A historical perspective On the Web |
American Roentgen Ray Society Images of Hemophilia A historical perspective |
Risk calculators and risk factors for Hemophilia A historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Hemophilia is sometimes referred to as “The Royal Disease”, as it affected many members of the English, German, Russian and Spanish monarchies in the 19th and 20th centuries.
Historical Perspective
The disease was first described by John Conrad Otto, an American physician, in 1803 based on his observation of affected men in certain families. In 1947, the first distinction between Hemophilia A and Hemophilia B was made by Dr. Alfredo Pavlovsky from Argentina. In 1965, through her work in the coagulation cascade, Dr. Judith Graham Pool discovered that cryoprecipitate left from thawing plasma was rich in Factor VIII. Soon after, the first use of cryoprecipitate to treat hemophilia A was pioneered.